ARCHIVES

CCOP Controversy Goes On: DCT Board Objects, Says It Was Left Out; Moorhead, DeVita Clarify Positions

This article is from The Cancer Letter archive.

Vol. 08 No. 08 | February 19, 1982

Download PDF Visit The Full Archive

Related Articles

Bush Budget Reinforces Funding Trends, Reports Say.

July 13, 2001

Existing HER2 Drugs May Help More In Breast Cancer Treatment

January 25, 2013

NCI-Approved Clinical Trials

October 29, 2004

Oncogens Variations May Exaplin Susceptibility, Familial Cancer, USC Investigators Report

September 23, 1988

Moddelmog Steps Down At Komen For the Cure

November 20, 2009

MUSC Hollings Cancer Center awarded NCI designation

February 1, 2021